See more : Synchrony Financial (SYF-PA) Income Statement Analysis – Financial Results
Complete financial analysis of Indo US Bio-Tech Limited (INDOUS.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Indo US Bio-Tech Limited, a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- Ambu A/S (AMBBY) Income Statement Analysis – Financial Results
- Kimberly-Clark de México, S. A. B. de C. V. (KCDMY) Income Statement Analysis – Financial Results
- Chesnara plc (CSN.L) Income Statement Analysis – Financial Results
- Brookfield Asset Management Inc (BROXF) Income Statement Analysis – Financial Results
- Beijing Bashi Media Co., Ltd. (600386.SS) Income Statement Analysis – Financial Results
Indo US Bio-Tech Limited (INDOUS.BO)
About Indo US Bio-Tech Limited
Indo US Bio-Tech Ltd. engages in the research, development, production, marketing and sale of all types of agriculture seeds. Its products include vegetable seeds, cotton seeds, oil seeds, spices seeds, pulses seeds, and cereals seeds. The company was founded on February 4, 2004, and is headquartered in Ahmedabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 728.36M | 617.45M | 500.53M | 401.10M | 0.00 | 353.48M | 294.43M | 244.87M |
| Cost of Revenue | 521.72M | 461.42M | 377.52M | 271.46M | 0.00 | 281.36M | 236.76M | 215.07M |
| Gross Profit | 206.64M | 156.03M | 123.01M | 129.64M | 0.00 | 72.12M | 57.67M | 29.80M |
| Gross Profit Ratio | 28.37% | 25.27% | 24.58% | 32.32% | 0.00% | 20.40% | 19.59% | 12.17% |
| Research & Development | 54.86M | 16.13M | 20.27M | 20.76M | 0.00 | 11.91M | 7.59M | 7.70M |
| General & Administrative | 16.42M | 0.00 | 0.00 | 10.23M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 3.70M | 0.00 | 0.00 | 16.30M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 20.12M | 53.87M | 35.26M | 26.54M | 0.00 | 28.23M | 24.17M | 10.36M |
| Other Expenses | 131.66M | -360.04K | -2.40M | 31.20M | 0.00 | -46.16K | -464.56K | -827.02K |
| Operating Expenses | 206.64M | 70.36M | 57.93M | 78.49M | 0.00 | 40.19M | 32.23M | 18.89M |
| Cost & Expenses | 728.36M | 531.78M | 435.45M | 349.96M | 0.00 | 321.55M | 268.99M | 233.96M |
| Interest Income | 122.21K | -41.25K | 25.64K | 16.72K | -1.01M | 16.12K | 1.43M | -6.54K |
| Interest Expense | 15.18M | 11.97M | 12.00M | 11.22M | 7.83M | 3.95M | 7.21M | 6.37M |
| Depreciation & Amortization | 8.00M | 8.26M | 4.37M | 2.59M | 0.00 | 2.55M | 1.69M | 1.47M |
| EBITDA | 110.15M | 94.10M | 71.27M | 53.10M | 38.60M | 34.61M | 29.30M | 13.05M |
| EBITDA Ratio | 15.12% | 15.21% | 13.88% | 13.24% | 0.00% | 9.75% | 9.21% | 5.06% |
| Operating Income | 112.98M | 85.67M | 65.08M | 51.15M | 0.00 | 31.93M | 25.44M | 10.91M |
| Operating Income Ratio | 15.51% | 13.88% | 13.00% | 12.75% | 0.00% | 9.03% | 8.64% | 4.46% |
| Total Other Income/Expenses | -24.93M | -11.80M | -11.97M | -11.86M | -9.06M | -3.82M | -5.24M | -6.37M |
| Income Before Tax | 88.04M | 73.87M | 54.90M | 39.29M | 0.00 | 28.11M | 20.40M | 5.20M |
| Income Before Tax Ratio | 12.09% | 11.96% | 10.97% | 9.80% | 0.00% | 7.95% | 6.93% | 2.13% |
| Income Tax Expense | 5.53M | 1.46M | 2.52M | -9.71M | 0.00 | 7.22M | 5.91M | 1.26M |
| Net Income | 82.51M | 72.40M | 52.37M | 49.00M | 0.00 | 20.88M | 14.49M | 3.95M |
| Net Income Ratio | 11.33% | 11.73% | 10.46% | 12.22% | 0.00% | 5.91% | 4.92% | 1.61% |
| EPS | 4.11 | 3.75 | 4.28 | 3.36 | 1.74 | 1.48 | 1.41 | 0.88 |
| EPS Diluted | 4.11 | 3.75 | 4.28 | 3.36 | 1.74 | 1.48 | 1.41 | 0.88 |
| Weighted Avg Shares Out | 20.05M | 19.29M | 12.24M | 14.56M | 14.56M | 14.09M | 10.27M | 4.47M |
| Weighted Avg Shares Out (Dil) | 20.05M | 19.29M | 12.24M | 14.56M | 14.56M | 14.09M | 10.27M | 4.47M |
Source: https://incomestatements.info
Category: Stock Reports